These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4137500)

  • 1. A double blind trial of a polyene macrolide--nystatin--in the treatment of benign prostatic hyperplasia in man.
    Bourke JB; Griffin JP; Theodorides P
    Br J Urol; 1974 Aug; 46(4):463-6. PubMed ID: 4137500
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of a polyene macrolide: nystatin.
    Theodorides P; Bourke JB; Griffin JP
    Proc R Soc Med; 1972 Feb; 65(2):130-1. PubMed ID: 4117438
    [No Abstract]   [Full Text] [Related]  

  • 3. Benign prostatic hypertrophy treated with a gestagen. A double-blind clinical trial with randomized allocation.
    Hald T; From A
    Scand J Urol Nephrol; 1972; 6():Suppl 15:157-6. PubMed ID: 4118753
    [No Abstract]   [Full Text] [Related]  

  • 4. Pills for the benign prostate. Trial designs.
    Castro JE
    Proc R Soc Med; 1972 Feb; 65(2):126-7. PubMed ID: 4117435
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of polyene macrolid compounds on plasma cholesterol and luteinizing hormone in man.
    Lunglmayr G; Spona J
    Int Urol Nephrol; 1973 Apr; 5(2):223-7. PubMed ID: 4129950
    [No Abstract]   [Full Text] [Related]  

  • 6. Medical treatment of enlarged prostate.
    Br Med J; 1971 Dec; 4(5788):638-9. PubMed ID: 4109163
    [No Abstract]   [Full Text] [Related]  

  • 7. A double-blind trial of the effects of candicidin on patients with benign prostatic hypertrophy.
    Abrams PH
    Br J Urol; 1977 Feb; 49(1):67-71. PubMed ID: 65196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, controlled, clinical trial of spironolactone for benign prostatic hypertrophy.
    Castro JE; Griffiths HJ; Edwards DE
    Br J Surg; 1971 Jul; 58(7):485-9. PubMed ID: 4104441
    [No Abstract]   [Full Text] [Related]  

  • 9. Candicidin in treatment of benign prostatic hypertrophy.
    Madsen PO; Dørflinger T; Frimodt-Møller PC; Jensen KM
    J Urol; 1984 Dec; 132(6):1235-8. PubMed ID: 6209428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled clinical trial of aldactone-A in the treatment of benign prostatic hyperplasia.
    Castro JE; Griffiths HJ; Edwards DE; Shackman R
    Br J Surg; 1969 Aug; 56(8):632. PubMed ID: 4185036
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of benign prostatic hyperplasia with finasteride and doxazosin -- long-term studies support the combination].
    Hausmann R; Thalmann G; Reich O; Steif CG
    Aktuelle Urol; 2004 Sep; 35(5):339-42. PubMed ID: 15383991
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current therapy of benign prostatic hypertrophy].
    Rist M
    Schweiz Rundsch Med Prax; 1986 Jul; 75(29):875-6. PubMed ID: 2426754
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of bromocriptine in patients with benign prostatic hypertrophy.
    Farrar DJ; Pryor JS
    Br J Urol; 1976 Feb; 48(1):73-5. PubMed ID: 57815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generalized dermatitis due to oral nystatin.
    Quirce S; Parra F; Lázaro M; Gómez MI; Sánchez Cano M
    Contact Dermatitis; 1991 Sep; 25(3):197-8. PubMed ID: 1838322
    [No Abstract]   [Full Text] [Related]  

  • 15. A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia.
    Champault G; Patel JC; Bonnard AM
    Br J Clin Pharmacol; 1984 Sep; 18(3):461-2. PubMed ID: 6207850
    [No Abstract]   [Full Text] [Related]  

  • 16. Nystatin-induced fixed eruption.
    Pareek SS
    Br J Dermatol; 1980 Dec; 103(6):679-80. PubMed ID: 6450606
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of obstructive symptomatology caused by prostatic adenoma with an extract of Serenoa repens. Double-blind clinical study vs. placebo].
    Tasca A; Barulli M; Cavazzana A; Zattoni F; Artibani W; Pagano F
    Minerva Urol Nefrol; 1985; 37(1):87-91. PubMed ID: 2413558
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of benign prostatic hypertrophy with progestational agents: a preliminary report.
    Wolf H; Madsen PO
    J Urol; 1968 Jun; 99(6):780-5. PubMed ID: 4172531
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of prostatectomy on the symptoms and signs of benign prostatic hypertrophy.
    Castro JE
    Br J Urol; 1973 Aug; 45(4):428-31. PubMed ID: 4125781
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute generalized exanthematous pustulosis following oral nystatin therapy: a report of three cases.
    Küchler A; Hamm H; Weidenthaler-Barth B; Kämpgen E; Bröcker EB
    Br J Dermatol; 1997 Nov; 137(5):808-11. PubMed ID: 9415247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.